Clinical Trial Update: A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH Patients

View source ↗

Summary

A retrospective non-interventional study evaluates the impact of eculizumab in Korean patients with paroxysmal nocturnal hemoglobinemia (PNH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Handok Inc. | Conditions: PNH | Status: COMPLETED